CDC advisers recommend resuming use of J&J's coronavirus vaccine; FDA to add blood clot warning

Vaccine advisers to the US Centers for Disease Control and Prevention voted Friday to recommend resuming use of the vaccine.

An updated warning will be added to the label.
The CDC and US Food and Drug Administration recommended pausing the use of the vaccine on April 13 while they investigated the risk of rare, severe blood clots. On Friday, members of the CDC's Advisory Committee for Immunization Practices agreed the benefits of the vaccine outweigh the risks from rare blood clots linked with the vaccine.